The biomedical accomplishment of human in vitro fertilization and embryo transfer (IVF-ET) took years to become the successful technique that presently enables infertile couples to have their own children. In 1969, more than ten years after the first attempts to treat infertilities with IVF technologies, the British developmental biologist Robert Geoffrey Edwards fertilized human oocytes in a Petri dish for the first time. In 1970, Edwards and his research partner, gynecologist and surgeon Patrick Christopher Steptoe, started working with human patients with complicated and individualized gynecological conditions. It took Edwards and Steptoe another eight years of modifying medical procedures, as well as dealing with the ups and downs of funding situations and public opinions, before they could celebrate birth of the first baby conceived through IVF-ET in 1978.

The National Embryo Donation Center (NEDC) is a non-profit organization that was established in 2002 in Knoxville, Tennessee. The organization is endorsed and supported by several Christian-based associations such as the Christian Medical Association, Bethany Christian Services, and Baptist Health Systems. Its goal is to provide embryo donation and embryo adoption services in order to utilize the large number of embryos that are being cryopreserved as a result of infertility procedures and are no longer needed. Jeffrey Keenan, Medical Director of the NEDC, is an OB/GYN, reproductive endocrinologist, and infertility specialist.

Various techniques constitute assisted reproduction, one of which is gamete intra-fallopian transfer (GIFT). The first example of GIFT involved primates during the 1970s; however, the technology was unsuccessful until 1984 when an effective GIFT method was invented by Ricardo Asch at the University of Texas Health Sciences Center and the procedure resulted in the first human pregnancy. The GIFT technique was created in hopes of generating an artificial insemination process that mimicked the physiological sequences of normal conception. The technique was further advanced at the Center for Reproductive Health at the University of California, Irvine, when Asch and his associate Jose Balmaceda employed a newly developed catheter into the GIFT procedure that eliminated the need for general anesthesia in the later stages of the procedure.

José Pedro Balmaceda was born 22 August 1948 in Santiago, Chile. His mother Juanita owned a women's boutique in the city and his father José was a successful owner of several timber mills. He grew up with five sisters who remained in Santiago all their lives. Balmaceda attended the college preparatory school San Ignatius where he met Sergio Stone, his future partner at the Center for Reproductive Health fertility clinic in the University of California Irvine Medical Center. In 1974 Balmaceda graduated from Catholic University Medical School and became a resident at the University of Chile hospital where he worked in obstetrics and gynecology.

Sergio Cereceda Stone was born 16 April 1942 in the coastal city of Valparaiso, Chile. Stone's mother Luz was a housewife and caretaker for Sergio and his younger brother Lionel; his father Sergio served among the country's twenty appellate court judges. In the early 1950s Stone's father relocated the family to Santiago to further his law career. There Stone attended the Jesuit elementary and high school Collegio San Ignatius, finished in the top ten percent of his class, and met José Balmaceda, his future coworker at the Center for Reproductive Health in Irvine, California. From San Ignatius, Stone went on to the University of Chile Medical School where he finished his obstetrics and gynecology residency. In 1969 he accepted a grant from the Ford Foundation for advanced research in endocrinology.

Jeffrey Keenan is the Director of the Southeastern Center for Fertility and Reproductive Medicine and the main developer behind the National Embryo Donation Center (NEDC) in Knoxville, Tennessee. This non-profit organization focuses on embryo donation and embryo adoption.

Established under the Assisted Human Reproduction (AHR) Act of 2004, Assisted Human Reproduction Canada (AHRC), also known as the Assisted Human Reproduction Agency of Canada, was created in 2006 to oversee research related to reproductive technologies and to protect the reproductive rights and interests of Canadian citizens. AHRC serves as a regulatory body for the development and use of such research and technology while enforcing the guidelines and restrictions laid out by the AHR Act.

Assisted reproductive technologies (ART) are a collection of different techniques designed to help those who are infertile achieve a successful pregnancy. The most popular technology currently in use is in vitro fertilization (IVF), but others include gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI). Although not encompassed under the umbrella term of ART, there are also various hormonal medications that can induce ovulation such as clomiphene citrate that can either be used alone to help women conceive, or used in conjunction with the above techniques. Infertility is a problem that has affected people throughout history, but it was only in the last half of the twentieth century that medical research developed technologies to help those who are infertile become pregnant.

Ricardo Hector Asch was born 26 October 1947 in Buenos Aires, Argentina, to a lawyer and French professor, Bertha, and a doctor and professor of surgery, Miguel. Asch's middle-class family lived among the largest Jewish community in Latin America, where a majority of males were professionals. After his graduation from National College No. 3 Mariano Moreno in Buenos Aires, Asch worked as a teaching assistant in human reproduction and embryology at the University of Buenos Aires School of Medicine where he received his medical degree in 1971.